Abstract
Delays in Time to Deterioration of Health-Related Quality of Life Were Observed in Patients with Acute Myeloid Leukemia Receiving Venetoclax in Combination with Azacitidine or in Combination with Low-Dose Cytarabine
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have